Marta Hałasa
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
Papers in
-
- Histone Deacetylase Inhibitors Research 9
- Epigenetics and DNA Methylation 7
- Ubiquitin and proteasome pathways 2
- Protein Degradation and Inhibitors 2
-
- Berberine and alkaloids research 3
- Co-authors
- Anna Wawruszak (16 shared papers)Andrzej Stepulak (14 shared papers)Estera Okoń (9 shared papers)Wirginia Kukuła‐Koch (5 shared papers)Joanna Kałafut (4 shared papers)Alicja Przybyszewska-Podstawka (3 shared papers)Karolina Okła (4 shared papers)Adolfo Rivero‐Müller (5 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)Cancers (3 papers)Results and problems in cell differentiation (1 paper)Anticancer Research (1 paper)Cancer Management and Research (1 paper)
- Partner nations
- PolandUnited StatesFinland
In The Last Decade
Marta Hałasa
23 papers receiving 495 citations
Peers
Comparison fields: 5 of 87
- Geriatrics and Gerontology 26
- Molecular Biology 336
- Oncology 100
- Pharmacology 28
- Cancer Research 45
Countries citing papers authored by Marta Hałasa
This map shows the geographic impact of Marta Hałasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Hałasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Hałasa more than expected).
Fields of papers citing papers by Marta Hałasa
This network shows the impact of papers produced by Marta Hałasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Hałasa. The network helps show where Marta Hałasa may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Hałasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 2021 | 84 | |
| 3 | 2019 | 55 | |
| 4 | 2021 | 54 | |
| 5 | 2020 | 52 | |
| 6 | 2020 | 34 | |
| 7 | 2020 | 19 | |
| 8 | 2019 | 17 | |
| 9 | 2019 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2018 | 15 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2019 | 5 | |
| 16 | 2021 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2025 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2022 | 3 |
About Marta Hałasa
Marta Hałasa is a scholar working on Molecular Biology, Pharmacology, Oncology, Plant Science and Geriatrics and Gerontology, having authored 24 papers that have together received 502 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Epigenetics and DNA Methylation (7 papers), Berberine and alkaloids research (3 papers), Ubiquitin and proteasome pathways (2 papers), Protein Degradation and Inhibitors (2 papers), Traditional and Medicinal Uses of Annonaceae (2 papers), Lanthanide and Transition Metal Complexes (2 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Geriatrics and Gerontology (26 citations), Molecular Biology (336 citations), Oncology (100 citations), Pharmacology (28 citations) and Cancer Research (45 citations). Marta Hałasa has collaborated with scholars based in Poland, United States and Finland. Frequent co-authors include Anna Wawruszak, Andrzej Stepulak, Estera Okoń, Wirginia Kukuła‐Koch, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Karolina Okła, Adolfo Rivero‐Müller, Lidia Borkiewicz and Małgorzata Guz. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Results and problems in cell differentiation, Anticancer Research and Cancer Management and Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.